LUMIIO
LIVE

Serial Number

99678850

Owner

Lumiio Inc.

Attorney

Bryan J. Massey

Filing Date

Mar 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

LUMIIO Trademark

Serial Number: 99678850

LUMIIO is a trademark filed by Lumiio Inc. on March 2, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Lumiio Inc.

4500-855 2 St SW
Calgary, AB T2P 4K7 , CA

Entity Type: 03

Trademark Details

Filing Date

March 2, 2026

Registration Date

Not Registered

Goods & Services

Providing use of online non-downloadable computer software for transmitting, processing, and displaying information relating to health indicators; Data automation and collection service using proprietary software to evaluate, analyze, and collect patient data; Design and development of integrated data collection and wireless transmission hardware systems for equipment and for software applications associated with that equipment at research facilities; Electronic monitoring and collection of patient data using computers and sensors; Electronic monitoring and collection of patient data using wearable activity trackers; Providing software as a service (SAAS) services featuring software for collecting, transmitting, processing, and displaying information relating to health data to and from patients and medical service providers; providing platform as a service (PAAS) services featuring software platforms for collecting, transmitting, processing, and displaying information relating to health data to and from patients and medical service providers; Providing software as a service (SAAS) services featuring software for health services management, research management, and database management; providing platform as a service (PAAS) services featuring software platforms for health services management, research management, and database management; Providing software as a service (SAAS) services featuring software to enable users to communicate via email, text messaging, and digital text messaging; Providing platform as a service (PAAS) services featuring software platforms to enable users to communicate via email, text messaging, and digital text messaging; Consultancy and advisory services relating to the design of medical and pharmaceutical patient studies for research purposes; Consultancy and advisory services relating to compliance with ethical guidelines in the design of medical and pharmaceutical patient studies for research purposes; Software as a service (SaaS) services featuring non downloadable software for securely organizing and tracking patient health data, electronic data capture (EDC) of patient research data, collection of patient-reported outcomes (PROs), clinical data warehousing, dashboarding and data visualization of patient health data, cohort discovery in the nature of identifying specific groups of patients who share common characteristics, tracking clinical outcomes measurement data in the field of medical research, and analyzing real-world medical research data; Consultancy services in the field of project management of medical research; all of the foregoing excluding any such services dedicated to or for use in the oral, dental health, or orthodontic sectors

Electronic data collection and compilation and submission services for business purposes in the fields of medicine and healthcare; Collection and analysis of quality metric data for medical researchers and clinicians for business purposes; Writing of grant proposals for medical researchers and clinicians; Advertising and marketing services provided by means of internal and external communications to customers, investors, universities and stakeholders for others; all of the foregoing excluding any such services dedicated to or for use in the oral, dental health, or orthodontic sectors

Downloadable computer software and mobile applications for securely organizing and tracking patient health data, electronic data capture (EDC) of patient research data, collection of patient-reported outcomes (PROs), clinical data warehousing, dashboarding and data visualization of patient health data, cohort discovery in the nature of identifying specific groups of patients who share common characteristics, tracking clinical outcomes measurement data in the field of medical research, and analyzing real-world medical research data; downloadable computer software platforms consisting of wireless networks and gateways for collection and management for patient data; Integrated computerized system for the collection, editing, organizing, analyzing, transmission, storage, and sharing of patient data and information related to medical analyses; Integrated computerized system for the collection, editing, organizing, transmission, storage and sharing of health indicators, namely, physical movement, pulse oximetry, gas analysis, vital signs, blood properties, and respiratory events; Downloadable computer software and software applications for monitoring and managing access to patient medical information; Downloadable computer software for monitoring patient medical information; all of the foregoing excluding any such goods dedicated to or for use in the oral, dental health, or orthodontic sectors

Health care services, namely, providing a database in the field of health care information processing and featuring inputting and collection of data and information for use in connection with treatment or diagnostic purposes; Providing medical information and health information via websites and patient portals in the fields of rare diseases, patient-reported outcomes, and real-world evidence; all of the foregoing excluding any such services dedicated to or for use in the oral, dental health, or orthodontic sectors

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 21, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 21, 2026 GNSL
SUSPENSION LETTER WRITTEN
Sep 21, 2026 CNSL
AMENDMENT FROM APPLICANT ENTERED
Sep 11, 2026 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2026 CRFA
ASSIGNED TO LIE
Sep 11, 2026 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 7, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 7, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 7, 2026 CNRT
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 6, 2026 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 6, 2026 PARI
ASSIGNED TO EXAMINER
Jun 30, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 29, 2026 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 29, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 2, 2026 MAFR
NEW APPLICATION ENTERED
Mar 2, 2026 NWAP